Tech Company Financing Transactions
Lucid Scientific Funding Round
Lucid Scientific closed a $7 million Series A funding round on 9/27/2023. Backers included IAG Capital Partners, Dynamk Capital and Georgia Research Alliance Venture Fund.
Transaction Overview
Company Name
Announced On
9/27/2023
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand production, sales and marketing, as well as broaden new product advancements.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
311 Ferst Dr. NW
Atlanta, GA 30332
USA
Atlanta, GA 30332
USA
Phone
Website
Email Address
Overview
Lucid Scientific is a biotechnology tools company working to accelerate drug discovery and basic biological research by providing systems for real-time cellular analysis. Originally developed at MIT, Lucid's patented RESIPHER system monitors cellular metabolism via non-invasive optical sensors, streaming information to researchers in real-time via a collaborative web platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Walker Inman
Chief Operating Officer
Eric Bleke
Browse more venture capital transactions:
Prev: 9/27/2023: Whipnotic venture capital transaction
Next: 9/27/2023: Sitryx Therapeutics venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs